Study raises new questions about Merck pill Zetia
Monday, November 16, 2009 - 06:21
in Health & Medicine
(AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.